Announcement of AISol Startup Program's First CertificationTSUKUBA CITY, Ibaraki Prefecture, Japan, June 5, 2023. Veneno Technologies Co. Ltd.
is pleased to announce that we have been certified as the first company in the AISol
Startup Program by AIST Solutions Co. (“AISol”)
AIST Solutions was established on April 1st of this year as a wholly-owned subsidiary ofthe National Institute of Advanced Industrial Science and Technology (AIST), Japan's
largest public research institution. Leveraging the technological assets and researchresources of the institute, AIST Solutions aims to enhance open innovation, fosterecosystem development, and create new businesses through proactive marketing
activities.
Veneno Technologies has been selected as the first AISol start-up in recognition of thecompetitiveness and business concept of the companyʼs proprietary DRP-based
technology for the discovery of new pharmaceuticals, agrochemicals, bio-chemicals, andother products.
“We are very honored to be recognized as the first AISol startup. With the support of theAIST group, we will continue to refine our technology and move forward with researchand development to realize our goal of innovative drug discovery as soon as possible.”,said Kazunori Yoshikawa, President and CEO of Veneno Technologies.
Mr. Seiji Osaka, President of AIST Solutions Co. commented, "Recognizing the significant
potential and business value of their innovative technology utilizing peptides, often
referred to as the dream of bio-pharmaceuticals, we have certified Veneno Technologies
as an AISol Startup and will provide full support to unleash its possibilities, including thedevelopment of new therapeutic drugs."

About AIST Solutions Co.
Company Name: AIST Solutions Co.
Location: (Tokyo) Hibiya Fort Tower, 1-1-1 Nishi-Shinbashi, Minato-ku, Tokyo(Tsukuba) 1-1-1 Umezono, Tsukuba City, Ibaraki
Representative: Seiji Osaka
HP: https://www.aist-solutions.co.jp

About AISol Startups
AIST Solutions identifies and certifies startup companies as AISol Startups, based on theircontribution to solving social challenges, technological competitive advantage, market
potential, and synergy with the AIST Group's management strategy.
AIST Solutions, in collaboration with AIST, will support the growth and commercializationof AISol Startups through various aspects such as engineering, marketing, businessacceleration, and capital reinforcement. Together, we will advance the businessdevelopment of AISol Startups.
For inquiries regarding this release, please contact:
Veneno Technologies Co. Ltd.
info@veneno.jp

ABOUT DRPs
Disulfide-Rich Peptide (DRP) is a generic term for peptides of about 20 to 60 amino acidresidues that have a characteristic structure with three or more disulfide bonds in themolecule. DRPs have a rigid molecular structure due to multiple disulfide bonds in themolecule, and are highly stable against heat, acid, and degrading enzymes compared tolinear peptides. DRPs are widely found in nature, from bacteria to humans, but they arealso found in animal venoms and have evolved as a major component of venoms to bepotent even in minute amounts. DRPs have been attracting attention in recent years as
a new basic molecule for drug discovery because of their excellent functions as naturalmodulators with high potency and selectivity.